FDA Simplifies Compassionate Use of Experimental Drugs, But Medical Marijuana Is Tricky
Terminally ill patients will soon have to cut through less red tape to get permission from the federal government to use experimental medications, including cannabis, in some states, to ease the suffering in the final days of their life.
The U.S. Food and Drug Administration recently announced a new compassionate use policy intended to make it easier for physicians to submit the necessary paperwork to gain access to experimental drugs for patients inflicted with serious or immediately life-threatening conditions for which there are no other treatments available.
Instead of forcing doctors to fill out a lengthy questionnaire, one that has often been considered a “laborious process,” the updated application now consists of 11 patient-specific questions that the health agency says should only take doctors around 45 minutes to complete. This policy update comes amid concerns that many physicians have been simply bypassing the compassionate use option because it is too...
This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.
Follow us on Instagram
Connect with us on Linkedin